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Abstract
As a group, patients with epilepsy have reduced neuropsychological functioning and health-related quality of life (HRQOL), but
the status of these factors is uncertain in seizure-free patients with seizure onset in adulthood on monotherapy. Nevertheless, some
of these patients report neuropsychological problems. We hypothesized that subtle impairments in neuropsychological functioning
and HRQOL may be underdiagnosed and related to these problems. Sixteen patients with localization-related epilepsy on mono-
therapy carbamazepine were compared with 16 age-, gender-, and education-matched healthy controls by means of a standardized
neuropsychological screening battery, questionnaires about HRQOL (Short-Form Health Survey, SF-36), self-perceived neuro-
psychological functioning (Cognitive Failure Questionnaire), and mood (Profile of Mood States). No objective impairments in
selective attention, memory, and executive functioning were found. However, a lower speed of information processing affecting
everyday life functioning was found. Lower levels of self-perceived neuropsychological functioning were reported, whereas HRQOL
was unimpaired relative to healthy controls. Physicians should not be reassured when patients receive adequate medication that
prevents seizures; careful follow-up of speed of information processing and self-perceived neuropsychological functioning is
needed.  2002 Elsevier Science (USA). All rights reserved.
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1. Introduction
Most studies into cognition and health-related quality
of life of patients with epilepsy do not distinguish be-
tween subgroups of epilepsy patients [1], although these
patients cannot be considered a homogeneous group [2].
High seizure frequency and seizure onset in childhood
are more likely to be associated with, for instance,
negative effects on the patients everyday life functioning
[3,4]. Other epilepsy-related factors such as early age at
seizure onset, duration of epilepsy, generalized seizures,
and polytherapy with antiepileptic drugs (AEDs) also
affect neuropsychological functioning [5–7] and health-
related quality of life (HRQOL) [8–12]. When research-
ers investigate patients with epilepsy who responded
positively to medication, they tend to include complex
or mixed patient groups, ranging from patients with
seizures and several AEDs to patients without ongoing
seizures on monotherapy. These differences in epilepsy-
related factors make firm conclusions about cognition
and HRQOL in epilepsy patients in general impossible
and thus distinct epilepsy groups should be studied
separately to disentangle the effects of epilepsy itself,
medication, and other factors.
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Due to improvements in medical and neurosurgical
treatment the subgroup of well-controlled epilepsy pa-
tients is growing. These patients no longer experience
seizures and are classified as well-controlled patients
because they are expected not to be limited in their daily
life by their epilepsy.
In their large study on 200 epilepsy patients who
attended regular jobs, Loiseau et al. [13] in 1983
showed that objective neuropsychological functioning
was impaired in comparison to healthy controls. Only,
31% of the patients were seizure-free and 72% had
epilepsy longer than 7 years. The patients included
were both well-controlled epilepsy patients and a small
number of recently diagnosed patients. In a recent
study of outpatients from a specialized epilepsy center,
‘‘relatively well-controlled’’ epilepsy patients were in-
vestigated who were treated with monotherapy, had
one seizure per month or less, and attended regular
jobs [14]. Fifty percent of the 56 patients were seizure-
free for more than 2 years and suffered from epilepsy
for more than 7 years. We showed impaired objective
neuropsychological functioning and lower levels of self-
perceived neuropsychological functioning, and there
was evidence of suppressed HRQOL compared with
matched healthy controls in this study [14]. Of the
studies on cognition mentioned above, none investi-
gated well-controlled epilepsy patients exclusively.
Therefore, no conclusions about the supposedly un-
impaired objective neuropsychological functioning in
these patients can be drawn.
In a study on HRQOL in well-controlled epilepsy
patients, high levels of adjustment to their chronic illness
and low levels of distress were reported [11]. HRQOL
appears to be unaffected, but well-controlled epilepsy
patients have never been compared with matched heal-
thy controls.
The aim of this study was to investigate whether
well-controlled epilepsy patients with late age at onset
and long duration of epilepsy who have been seizure-
free for more than 2 years have impaired objective
neuropsychological functioning and suppressed
HRQOL and report impaired self-perceived neuro-
psychological functioning compared with matched
healthy controls. If the self-perceived neuropsycho-
logical functioning was suppressed among this group,
the next step was to investigate if it could be associ-
ated with impaired objective neuropsychological
functioning, suppressed HRQOL, or suppressed mood
of the patients. The patient and control groups
were compared on measures related to attentional
processes, memory functioning, and speed of
information processing. These measures were se-
lected because of earlier research that had shown
sensitivity in the detection of subtle neurocognitive
impairments in patient groups (e.g., cognitive aging)
[15].
2. Methods
2.1. Patients and procedures
One hundred eighty-four eligible outpatients with
partial epilepsy were identified from January to March
1998 from three outpatient clinics of the Dutch Epilepsy
Clinics Foundation in The Netherlands (Heemstede,
Amsterdam, and Utrecht). First, medical chart audits
were performed to check inclusion criteria: (1) partial
epilepsy; (2) carbamazepine (CBZ) monotherapy; (3)
18P age6 65. Exclusion criteria were: (1) present use of
psychoactive drugs or antiepileptic drugs other than
CBZ; (2) additional neurological or psychiatric disease;
(3) severe perceptual deficits; (4) a history of head injury,
status epilepticus, neurosurgery, or neuropsychological
evaluation within the last year. The eligibility criteria
based on information of the medical charts were met by
148 outpatients. In the second step, 70 patients from
whom informed consent was received were tested. The
selection procedure is described in detail elsewhere [14].
To select well-controlled epilepsy patients, the fol-
lowing criteria had to be met; (i) seizure-free for at least
2 years; (ii) epilepsy duration of at least 7 years; (iii)
epilepsy onset after completion of high school. These
three criteria excluded possible effects of confounding
factors. Eventually, 16 patients remained.
Educational attainment was rated on an ordinal scale
ranging from 1 (incomplete primary) to 8 (university); 2
points on this scale indicate a completed primary edu-
cation, and 5, 6, and 7 points indicate completed lower,
middle, and higher secondary education, respectively.
A control group of healthy persons was selected
comparable in age, gender, and education to the patient
group from a large, cross-sectional study of the biolog-
ical and psychological determinants of cognitive aging
involving 1940 subjects aged 25–80 years: the Maastricht
Aging Study [16]. These persons had been carefully
screened for medical and psychosocial risks potentially
affecting cognitive functioning, and can be regarded as
an optimal normative control group of healthy controls.
For the questionnaire about HRQOL, the SF-36 Health
Survey, an individually matched sample on age, sex, and
education was drawn from other normative data [17].
This questionnaire was validated among healthy Dutch-
speaking residents [18]. No data for the Dutch short
version of the Profile of Mood States (POMS) were
available for these groups of matched healthy persons.
2.2. Neuropsychological functioning
An Intelligence Quotient estimate was made by
means of the Dutch version of the Primary Mental
Abilities test called the Groninger Intelligence Test
(GIT) [19]. Three different cognitive domains were
studied.
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Selective Attention was indexed by the Stroop Color–
Word Test (SCWT) [20]. In this test, subjects have to
read words on card I, and subsequently name colors on
card II. Card III involved color names again, but the
printing ink was different from the color name. The
subjects were asked to name the color of the printing ink
and not read the word that interfered, all as fast as they
could. Lower scores indicate better performance. Inter-
ference is expressed by the score on card II subtracted
from the score on card III.
Verbal memory was assessed with the Auditory Ver-
bal Learning Test (AVLT) [21]. Here a subject is asked
to learn 15 nonrelated words over five auditory trials.
Primary recall after the first presentation is considered a
measure of working memory. Memory encoding and
retrieval are tested in the delayed recall after 20 min.
More remembered words indicate better memory func-
tion.
Retrieval from semantic memory was indexed by the
Categoric Word Fluency Task (Fluency) [22], which
consists of one subtask, in which subjects are asked to
name as many animals as they could within 1 min
(Fluency). The performance on this task is taken as a
measure of retrieval from semantic memory. This vari-
able is usually considered to reflect an important aspect
of executive functioning. Higher scores indicate better
executive functioning.
2.3. Self-perceived health-related quality of life
Self-perceived health-related quality of life was as-
sessed by means of the Short-Form Health Survey (SF-
36) [18]. The SF-36 is a self-report questionnaire that
covers the following eight dimensions of health: physical
functioning, role limitations due to physical health
problems, bodily pain, general health perceptions,
vitality, social functioning, role limitations due to
emotional problems, and general mental health. Two
higher-order compound scores are computed: mental
compound score (MCS) and physical compound score
(PCS). Higher scores indicate better HRQOL.
2.4. Self-perceived neuropsychological functioning
Self-perceived neuropsychological functioning was
assessed using the Cognitive Failure Questionnaire
(CFQ) [23], a 25-item self-report questionnaire that re-
quires subjects to provide ratings of the perception of
frequency of various cognitive slips in daily life, higher
scores indicating more cognitive slips (CFQ).
2.5. Self-perceived mood
Self-perceived mood was investigated with the Dutch
short version of the POMS to measure the extent to
which mood influences test scores [24]. The question-
naire consists of 32 words that describe mood states.
Adult and geriatric normative data and validation of the
profile of mood states are available for the Dutch pop-
ulation [25].
2.6. Data analysis
Univariate analysis of variance (ANOVA) was used
to determine if objective, self-perceived neuropsycho-
logical performance and self-perceived HRQOL of the
well-controlled patients differed from those of the heal-
thy controls (see Table 2). To correct for multiple testing
we restricted a to 1%.
To investigate the association between overall self-
perceived neuropsychological functioning investigated
with the CFQ total score, objective neuropsychological
functioning as indexed by Total Recall score (VVLT),
card I (SCWT), Interference score (SCWT), and overall
self-perceived HRQOL measured with MCS and PCS,
Pearsons correlations were calculated. In addition, as-
sociations between the five subscales of the POMS
(tension, depression, anger, vigor, and fatigue) and the
four dimensions of the CFQ (absentmindedness, prob-
lems with social interactions, difficulties remembering
names and words, difficulties with orientation) were in-
vestigated.
3. Results
Table 1 lists the patients clinical and biographical
characteristics. The mean age of the patients was 45.9
years. Eleven of the sixteen patients were male. The
mean duration of epilepsy was 16 years, ranging from 7
to 41 years. The mean age at onset was 30 years, ranging
from 18 to 48 years. The epileptogenic zone was local-
ized to the frontal lobe in four patients, the temporal
lobe in five patients, the frontotemporal in six patients,
and the occipital lobe in one patient.
The healthy controls were matched successfully since
they had a mean age of 45.5 years, and 11 patients were
male. The level of education ranging from level 1 to level
8 was 5.3 compared with 5.6 in the patient group. Thus,
all patients completed lower secondary education. The
IQ estimate for the patients (115.8) did not differ sig-
nificantly from that for the healthy controls (116.3)
(F ¼ 0:023). These estimates based on GIT scores are
above average. There were statistically significant dif-
ferences in age, sex, and education between the groups.
The results of the patient and healthy control groups
were free of statistical outliers (all data fell within 2 SD
of the group mean), indicating that the overall results
are not disproportionately influenced by the test per-
formance of one particular patient or control.
Patients did not show evidence of any difficulty with
selective attention functioning (SCWT, card III
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F ¼ 1:228 and Interference F ¼ 5:773). Slower infor-
mation processing was found when patients had to read
words and name colors (SCWT) (card I F ¼ 7:686,
P ¼ 0:008, and card II F ¼ 11:590, P ¼ 0:003) (Table 2).
No problems with memory functioning were found on
primary recall of newly presented information or long-
Table 2
Neuropsychological test scores and scores on subscales of the SF-36, measuring health-related quality of life (HRQOL) of patients with well-con-
trolled epilepsy and healthy controlsa
Variables Patients with epilepsy (n ¼ 16) Healthy controls (n ¼ 16) P b
Neuropsychological test scores
IQ estimate
GIT sum (nc) 115:8 0:165 116:3 12:2 NS
Memory (VVLT)
Trial 1 (nc) 6:4 1:5 6:1 1:6 NS
Max (nc) 11:1 2:4 12:0 2:0 NS
Delta (nc) 4:7 2:0 5:9 2:0 NS
Total recall (nc) 44:0 10:0 47:5 8:3 NS
Delayed recall (nc) 9:1 2:8 9:4 3:3 NS
Attention (SCWT)
Card I (s) 46:0 8:6 38:7 4:6 <0.008
Card II (s) 60:3 10:6 49:9 6:4 <0.003
Card III (s) 90:1 21:0 83:4 14:3 NS
Interference (s) 29:0 15:6 33:4 11:6 NS
Executive function
Fluency (nc) 25:0 5:8 24:4 5:7 NS
HRQOL scores (SF-36)c
Physical compound score (PCS) 47:8 8:3 50:0 9:2 NS
Mental compound score (MCS) 46:7 9:4 52:7 12:6 NS
Self-perceived neuropsychological functioning (CFQ)d
Total score 46:2 13:7 30:9 11:2 <0.002
a See methods for explanation of abbreviations of variables. nc, Number of correct responses.
bValues of univariate analyses of variance (ANOVAs) between patients with epilepsy and healthy age-, gender-, and education-matched controls.
cHealthy controls for the SF-36 were derived from a different sample than the sample for the neuropsychological tests. Higher scores indicate better
HRQOL.
dHigher scores indicate more problems with self-perceived neuropsychological functioning.
Table 1
Demographic and clinical characteristics
Patient Gender Age Educational
levela
Age at
onset
Seizure
duration
Seizure
typeb
Localization Lateralization CBZc
dosage
(mg)
Serum
level
(mg/L)
1 F 39 4 21 18 IB+ ICc Frontotemporal Right 1000 8.3
2 M 59 1 37 22 IB+ IC Temporal Left 800 9.5
3 M 52 8 43 9 IA+ IC Frontotemporal Left 600 6.5
4 M 55 7 48 7 IB+ IC Frontotemporal Left 100 3.0
5 M 37 4 26 11 IB+ IC Frontotemporal Left 800 6.3
6 M 34 7 27 7 IB Frontal Unknown 400 5.8
7 F 48 8 36 12 IA+ IB Frontal Left 600 4.7
8 M 40 6 22 18 IA Occipital Right 800 8.6
9 M 62 6 21 41 IB+ IC Frontal Left 400 4.9
10 M 29 4 18 11 IB+ IC Frontal Left 800 7.0
11 M 54 6 41 13 IB+ IC Temporal Unknown 800 4.9
12 F 37 3 28 9 IA Temporal Left 400 6.8
13 M 57 8 22 35 IB+ IC Temporal Right 1000 5.1
14 F 33 5 25 8 IA+ IC Temporal Left 600 7.4
15 M 48 3 40 8 IB+ IC Frontotemporal Right 400 8.0
16 F 50 8 26 24 IA+ IB Frontotemporal Left 400 6.0
a Educational level was classified according to a Dutch scoring system, ranging from 1 (incomplete primary) to 8 (university).
b IA, simple partial seizures, IB, complex partial seizures, IC, secondarily generalized seizures.
c CBZ, carbamazepine.
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term memory consolidation (F ¼ 0:098 and F ¼ 0:052,
respectively). Executive functioning was also not im-
paired (F ¼ 0:333).
Self-perceived health-related quality of life is also
depicted in Table 2. On average, the SF-36 compound
scores showed no significant difference between the pa-
tients and the healthy controls (PCS F ¼ 0:545 and
MCS F ¼ 2:433). However, self-perceived neuropsy-
chological functioning (CFQ) (total score) was lower in
the patient group than in the healthy controls
(P ¼ 0:002, F ¼ 12:049).
There were no statistically significant correlations
between self-perceived neuropsychological functioning
(CFQ), on the one hand, and objective neuropsycho-
logical functioning in any cognitive domain, self-per-
ceived health-related quality of life (MCS, PCS), and
self-perceived mood (POMS), on the other hand.
4. Discussion
The aim of this study was to investigate if seizure-free
patients have normal objective neuropsychological
functioning and HRQOL, although they may report
lower levels of self-perceived neuropsychological func-
tioning.
Overall self-perceived health-related quality of life is
not suppressed in the present study which is in ac-
cordance with previous studies on well-controlled ep-
ilepsy [11,26]. However, lower levels of self-perceived
neuropsychological functioning were reported by the
patients in the present study. This is in accordance
with our previous study on relatively well-controlled
epilepsy patients [14]. The performance of the patients
was slower than that of healthy controls. No impair-
ments in selective attention, memory functioning, or
executive functioning were found. However, these
findings contrast with our previous study [14], in
which we found impaired neuropsychological func-
tioning on all cognitive domains mentioned above. It
confirms the notion that well-controlled epilepsy pa-
tients with an age of onset after 18 years with a long
duration of epilepsy and without seizures are a distinct
category of patients different, than the more elaborate
patient group mentioned above, as demonstrated re-
cently by Shackleton et al. [26]. These patients did
experience a maximum of one seizure per month,
without restrictions in age at onset and epilepsy du-
ration.
Early detection of slowness is important to be able to
offer patients a cognitive rehabilitation program aimed
at improving information processing [27] in daily life
functioning.
The diminished speed of information processing we
found has also been established by pharmacological
studies and might be due to the carbamazepine medi-
cation [28,29]. Although CBZ dosage and serum level
were not related to cognition in our previous study on
relatively well-controlled epilepsy [14], in this study the
serum level was within the standard therapeutic range
which makes it unlikely to find a correlation. We
therefore cannot exclude that cognitive slowing can be
partially due to CBZ.
Self-perceived neuropsychological functioning ap-
peared not to be related to objective neuropsychological
functioning, HRQOL, and mood. Other studies could
not find a simple association between self-perceived
neuropsychological functioning and objective neuro-
psychological functioning as well [30].
Since no association with cognition was found, we
discuss other determinants that might result in low
levels of self-perceived neuropsychological functioning.
First, differential cognitive behavior is a possible de-
terminant for the problems the patients report about
cognitive functioning. Differential cognitive behavior
means individual differences in the success with which
patients use devices and techniques to improve cogni-
tive processes. Inadequate cognitive behavior may re-
sult in cognitive complaints. Only then it is advisable to
offer time-consuming cognitive rehabilitation programs
since they can provide the patient with new insights
[31]. In line with this reasoning, coping strategies as
applying avoidance rather than problem-focused cop-
ing strategies are found to be related to adjustment
problems and could give rise to cognitive complaints.
However, this effect was studied only in a mixed pa-
tient group including well-controlled epilepsy patients
[32].
Second, factors related to chronic illness rather than
epilepsy per se can be held responsible for the lower
levels of self-perceived neuropsychological functioning.
The limitation of activities and aspirations and the
various social and economic stresses associated with
chronic disorders in general may give rise to negative
self-evaluations. As a result some chronically ill subjects
may overestimate their cognitive problems [30]. Brown
and McNeill [33] also suggested that memory complaints
may represent a combination of general dissatisfaction
with psychosocial status as well as self-perceived limi-
tations in abilities. If coping strategies are not adequate
and difficulties with accepting a chronic illness are ob-
served, referral to a psychologist for counseling seems
more appropriate than cognitive rehabilitation
programs.
A limitation of this study is the small sample size of
our group, but this is a consequence of the carefully
chosen inclusion and exclusion criteria that make our
patient group unique in the current literature on objec-
tive neuropsychological functioning and HRQOL in
epilepsy. A limited number of tests and questionnaires
were administered to minimize the possibility of finding
significant results due to chance factors. However, we
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selected the test so that all important cognitive areas
were covered.
To summarize, the present data support the as-
sumption that well-controlled epilepsy patients with late
age at onset and relatively long duration of epilepsy
have no overall impaired HRQOL. However, when self-
perceived neuropsychological functioning was investi-
gated in detail, difficulties were reported. Lower speed of
information processing was also found. Therefore, when
patients become seizure-free with adequate medication,
cognition still needs to be monitored by the psycholo-
gist.
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